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Abstract
Background: Detection of psychotic disorders is an important issue, since early treatment might
improve prognosis. Timely diagnosis of psychotic disorders depends on recognition of psychotic
symptoms and their interpretation. The aim of this study is to examine to what extent reported
psychotic symptoms are accounted for in clinical diagnosis.
Methods: The medical files of all patients who had a first contact with one of two mental health
care services (N = 6477) were screened for reported psychotic symptoms and subsequent clinical
diagnosis. Patients who reported psychotic symptoms and who were diagnosed with a psychotic
disorder were followed-up for two years to register prescription of antipsychotic treatment and
continuity of care.
Results: In the files of 242 (3.7%) patients specific psychotic symptoms were recorded. 37% of
these patients were diagnosed with a non-affective psychotic disorder, 7% with other psychotic
disorders and 56% with non-psychotic disorders or no diagnosis at all. About 90% of the patients
diagnosed with a psychotic disorder did receive any prescription of antipsychotics, and about 50%
were in continuous care during the first 2 years.
Conclusion: Relatively large proportions of patients presenting with psychotic symptoms were
diagnosed with a non-psychotic diagnosis or not diagnosed at all. This applies also to patients
reporting at least two or more psychotic symptoms. Although we did not verify the
appropriateness of clinical diagnosis, these findings are an indication that psychotic disorders may
be underdetected. Improving the diagnostic process in mental health care services may be the most
obvious way to promote early intervention in psychosis.
Background
Early detection and intervention of psychotic disorders are
important issues in mental health practice and research
[1,2]. Different strategies have been developed to improve
the detection of first episode psychosis both in the pro-
dromal phase and during the first psychotic episode to
minimize the delay of treatment after the onset of psycho-
sis [3,4]. The role of treatment delay has been shown to be
an important factor associated with response to antipsy-
chotic treatment, in terms of severity of global psychopa-
thology, positive and negative symptoms, functional
outcomes and time to response [5-7]. As a consequence, it
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was hypothesized that reducing the duration of untreated
psychosis would improve outcome [8-13]. Therefore it is
essential that patients who report psychotic symptoms at
first contact with mental health services are adequately
diagnosed and treated accordingly. The APA practice
guidelines for the treatment of patients with schizophre-
nia [14,15] as well as the Dutch guidelines [16] provide
recommendations for treatment in every phase of the ill-
ness. The most important interventions for first episode
psychosis are: accurate diagnostic assessment, initiating
antipsychotic medication as soon as it is feasible, and con-
tinuation of antipsychotic treatment after response for at
least one year in the APA guidelines and at least two years
in the Dutch guidelines. The recommended duration of
antipsychotic prophylaxis in the Dutch guidelines is one
year longer, because relapse rates do not seem to level off
during the first years after remission from a first episode
[17].
Despite the importance of treatment guidelines, however,
implementation has been shown to be difficult to achieve
[18-20]. The aim of the study is to examine to what extent
reported psychotic symptoms are accounted for in clinical
diagnosis and subsequent treatment.
Methods
Study design
The design of the study is an administrative inquiry into
the diagnostic and daily practice of mental health care
services regarding patients who report psychotic symp-
toms at first contact. The study was conducted in two
mental health regions of The Netherlands, with 1.028 mil-
lion inhabitants on January 1, 2002. The two regions were
Friesland (636,000 inhabitants) and Twente (392,000
inhabitants). The total number of inhabitants between
18–45 years of age, representing the at risk population,
was 404,909, of which 210,294 (51.9%) were males.
The medical records of all patients between 18–45 years of
age who had a first contact with mental health care serv-
ices in 2002 were screened for reported specific psychotic
symptoms and their initial clinical DSM-IV diagnosis. All
available documents from the first six months after first
contact were taken into account. Patients with at least one
of four specific psychotic symptoms were included and
followed-up for two years. The psychotic symptoms
screened for were the symptoms listed under paragraph A
in the schizophrenia section of the DSM-IV: delusions,
hallucinations, disorganized speech and grossly disorgan-
ized behaviour [21]. After thirty months of follow-up
medical files were screened retrospectively for final DSM-
IV diagnosis, any prescription of antipsychotic treatment
and continuity of care during two year follow up.
Results
Of 404,909 inhabitants between 18–45 years of age, 6477
(1.6%) were referred to mental health services for a first
ever contact in 2002. The medical files of 892 patients
were excluded (14%) due to lack of information (526) or
availability (366). 5585 medical files were eligible for fur-
ther research. In the files of 242 patients one or more spe-
cific psychotic symptoms were reported; 140 patients
(58%) were males. In 182 files delusions were reported, in
90 files hallucinations, in 37 files grossly disorganized
behaviour and in 17 files disorganized speech.
As shown in table 1, at baseline 90 patients (37%) were
diagnosed according to DSM-IV with a non-affective psy-
chotic disorder (NAPD): schizophrenia, schizophreni-
form disorder, brief psychotic disorder, schizoaffective
disorder, delusional disorder or psychotic disorder not
otherwise specified. 17 patients (7%) were diagnosed
with other psychotic disorders: organic or substance
induced psychotic disorder (n = 6), affective episode with
psychotic features (n = 6) or schizophrenia spectrum per-
sonality disorder [5]. The other 135 patients were diag-
nosed with non-psychotic disorders (n = 77, 32%) or were
not diagnosed at all (n = 58, 24%). 75 patients (31%)
who reported psychotic symptoms had a combination of
two or more psychotic symptoms, of whom 45 were diag-
nosed with a non-affective psychotic disorder (NAPD)
and the other 30 patients with other psychotic disorders
or a non-psychotic disorder. 16 patients (53%) were diag-
nosed as a non-affective psychotic disorder sometime dur-
ing the follow-up period. A combination of at least three
symptoms was reported in the records of 9 patients. Of the
167 patients with one reported psychotic symptom, 45
(27%) were diagnosed with a non-affective psychotic dis-
order.
As shown in table 2, antipsychotic medication has been
prescribed anytime during the follow-up period to 158
patients (65%). Of the 90 patients with a non-affective
psychotic disorder antipsychotics were prescribed to 81
patients (90%). Of the patients diagnosed with other psy-
chotic disorders (n = 17), 88% received a prescription of
antipsychotic medication. Patients diagnosed with other
Table 1: Psychotic symptoms per diagnostic group
NAPD OPD Other None N
1 sx 45 (27%) 12 (7%) 61 (37%) 49 (29%) 167 (100%)
2 sx 40 (61%) 3 (5%) 15 (23%) 8 (12%) 66 (100%)
3 sx 4 (50%) 2 (25%) 1 (12.5%) 1 (12.5%) 8 (100%)
4 sx 1 (100%) 0 0 0 1 (100%)
NAPD = non-affective psychotic disorder
OPD = other psychotic disorders
Other = other disorders
Sx = symptomsClinical Practice and Epidemiology in Mental Health 2008, 4:29 http://www.cpementalhealth.com/content/4/1/29
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disorders or without any specified diagnosis received a
prescription of antipsychotic medication in 46%. Of the
90 NAPD patients, 46 (51%) received continuous care for
at least two years.
Discussion
The present study, in which more than 5500 medical files
were studied from the population of two mental health
regions, revealed that many patients presenting psychotic
symptoms are not adequately diagnosed. Even when two
psychotic symptoms are presented, 25% of patients
received a non-psychotic diagnosis or no diagnosis at all.
In case one psychotic symptom was stated in the files, the
chance of getting a psychotic diagnosis is only 33%. These
data strongly indicate that psychosis in mental health care
is under detected. We were not able to estimate the preva-
lence of underdetection of psychosis because of a number
of limitations of the study. We were not able to verify clin-
ical diagnosis by a standardized diagnostic procedure, and
therefore some of the clinically assigned diagnoses might
indeed be appropriate (e.g. in case of PTSS or personality
disorder with psychotic symptoms). This study com-
pletely relied on reported psychotic symptoms as written
in the medical files. Such symptoms might not have been
recorded or even noticed and therefore have escaped
proper attention. Underdetection of psychotic symptoms
may also contribute to underdetection of NAPD. System-
atic examination of psychotic experiences at first contact
with mental health services may serve as a useful measure
to overcome this limitation of our study and of clinical
practice. The results did not differ between the two regions
with only two mental health care services which were
both included in the study, so it is unlikely that local fac-
tors played an improtant role or that patients received
treatment elsewhere.
90% of the patients clinically diagnosed with a non-affec-
tive psychotic disorder received at least one prescription of
antipsychotic medication while half of them received con-
tinuous care for at least two years. We may conclude that
if clinical diagnosis of a non-affective psychotic disorder
has been established, proper treatment consequences are
more or less assured. This underlines the importance of
timely detection of psychotic disorder by mental health
care services. Effort should be primarily directed to
patients referred to mental health care services in stead of
to individuals who do not yet seek help.
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